Diabetes Technology Clinical Trials
Researchers are investigating cutting-edge technologies, like enhanced CGM and AID systems, to optimize glucose control. These ongoing trials are currently recruiting participants.
Advances in diabetes technology are at the forefront of better glucose management and improved health overall for people with diabetes.
Here are several trials recruiting participants to test new technologies, including continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems:
Researchers are recruiting adults with both type 2 diabetes and obesity to test if the combination of WeightWatchers and CGM helps lower A1C.
While AID systems have been shown to increase time in range in type 1 diabetes, less is known about the benefits in type 2 diabetes. Participate in studies evaluating Control-IQ, MiniMed 780G, and Omnipod 5 AID systems and shape the future of type 2 diabetes care.
Adults with type 1 or type 2 diabetes will be enrolled in one of two virtual stress-intervention courses to measure changes in A1C, diabetes distress, and more.
Scripps Whittier Diabetes Institute is researching how to support people living with type 1 diabetes. Participants will receive money and personalized resources.
More clinical trials to watch out for:
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features: This study is researching the accuracy and safety of the Eversense implantable CGM with new features in adults with type 1 or type 2 diabetes and children with type 1 diabetes.
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®: This trial is investigating the safety and efficacy of Medtronic’s MiniMed 780G AID system in children and adults with type 1 diabetes who use the rapid-acting insulin Fiasp.
Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults (RADIANT): This study, based in Europe, will examine the safety and efficacy of the Omnipod 5 AID system with the FreeStyle Libre 2 CGM compared to multiple daily injections with the FreeStyle Libre 2 CGM in children and adults with type 1 diabetes.
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age (Dulce Digital): Researchers are investigating the efficacy of different digital approaches to diabetes self-management education compared to traditional in-person education programs among Hispanic adults with type 2 diabetes.
Learn more about type 2 diabetes research and technologies here: